中国专家成功研发可溯源AI诊断系统 破解罕见病诊断世界性难题

Core Viewpoint - The article highlights the development of DeepRare, the world's first traceable intelligent diagnostic system for rare diseases, which addresses the global challenge of diagnosing rare diseases effectively [1][2]. Group 1: DeepRare's Technological Advancements - DeepRare utilizes a pioneering "Agentic AI" architecture that enhances traditional medical AI by providing a clear reasoning process, thus overcoming the "trust crisis" associated with conventional AI systems [2]. - The system integrates vast medical literature and clinical case data, enabling a deep understanding of medical knowledge rather than simple information retrieval [2]. - DeepRare demonstrates a "phenotype decoding" capability, achieving a first-position diagnostic accuracy of 57.18% based solely on clinical phenotype information, which is a 23.79 percentage point improvement over previous models [3]. Group 2: Performance and Application - When gene sequencing data is included, DeepRare's diagnostic accuracy exceeds 70.6%, significantly outperforming the commonly used Exomiser tool, which has an accuracy of 53.2% [3]. - The DeepRare online diagnostic platform was launched on July 26, 2025, and has quickly gained recognition, attracting over 1,000 professional users and covering more than 600 medical and research institutions globally [3]. Group 3: Future Initiatives - DeepRare is currently undergoing internal testing at Xinhua Hospital and will serve as a digital quality control tool in the rare disease diagnosis process [4]. - A "Global AI Rare Disease Diagnosis Alliance" is being established, along with a "10,000 Clinical Validation Plan" to validate DeepRare's performance through real-world testing of 20,000 rare disease cases [4].